The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CRISPR Therapeutics AG(NASDAQ:CRSP) 
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technolo...
Website: http://www.crisprtx.com
Founded: 1987
Full Time Employees: 458 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
CRISPR Therapeutics Number of Employees
CRISPR Therapeutics Days Payable Outstanding ttm (DPO)
CRISPR Therapeutics Days Receivable Outstanding ttm (DSO)
CRISPR Therapeutics Op Cashflow Per Share ttm
CRISPR Therapeutics Free Cashflow Per Share ttm
CRISPR Therapeutics Cash Per Share ttm
CRISPR Therapeutics P/S ratio ttm
CRISPR Therapeutics (GAAP) P/E ratio ttm
CRISPR Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.